| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Elucid A medical technology company using AI-powered, clinically validated software to advance precision diagnosis and treatment of cardiovascular disease | Series B Verified against 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date. | $27M | 2022-06-22 | [ PART ] |